SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001345281-23-000006
Filing Date
2023-11-16
Accepted
2023-11-16 16:13:09
Documents
1
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 15058
  Complete submission text file 0001345281-23-000006.txt   16613
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Issuer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O 225 LONG AVENUE HILLSIDE NJ 07205
Business Address
KAY E GERALD (Reporting) CIK: 0001053310 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31668 | Film No.: 231414738